GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » NonCurrent Deferred Liabilities

G.Barekat Pharm (XTEH:BRKT1) NonCurrent Deferred Liabilities : IRR0 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

G.Barekat Pharm's non-current deferred liabilities for the quarter that ended in Mar. 2017 was IRR0 Mil.

G.Barekat Pharm NonCurrent Deferred Liabilities Historical Data

The historical data trend for G.Barekat Pharm's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm NonCurrent Deferred Liabilities Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
NonCurrent Deferred Liabilities
- -

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
NonCurrent Deferred Liabilities - -

G.Barekat Pharm NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines